| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 148 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 136 |
| 2 | TACROLIMUS OINTMENT 0.1% | 136 |
| 3 | MYCOPHENOLATE MOFETIL | 99 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 99 |
| 5 | PREDNISONE | 78 |
| 6 | DEXAMETHASONE | 65 |
| 7 | DEXAMETHASONE 1.5 MG | 65 |
| 8 | PREDNISOLONE | 65 |
| 9 | PREDNISOLONE ORAL | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONASEMNOGENE ABEPARVOVEC-XIOI | 9 | 0.0039 |
| 1 | SIROLIMUS | 37 | 0.0027 |
| 2 | PALONOSETRON HYDROCHLORIDE | 12 | 0.0022 |
| 3 | QUININE | 19 | 0.0022 |
| 4 | CLINDAMYCIN PHOSPHATE | 11 | 0.0020 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 14 | 0.0017 |
| 6 | CARFILZOMIB | 39 | 0.0014 |
| 7 | ELOTUZUMAB | 6 | 0.0012 |
| 8 | TACROLIMUS OINTMENT 0.1% | 136 | 0.0011 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 136 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 224 |
| 1 | Platinum-based Drug [EPC] | 70 |
| 2 | Kinase Inhibitor [EPC] | 63 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 60 |
| 4 | Alkylating Drug [EPC] | 58 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 54 |
| 6 | mTOR Inhibitor Immunosuppressant [EPC] | 53 |
| 7 | Proteasome Inhibitor [EPC] | 48 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| 9 | Complement Inhibitor [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 1 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 6 | 0.0012 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 14 | 0.0011 |
| 3 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 3 | 0.0007 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 15 | 0.0007 |
| 5 | Complement Inhibitor [EPC] | 39 | 0.0007 |
| 6 | Penem Antibacterial [EPC] | 23 | 0.0007 |
| 7 | Somatostatin Analog [EPC] | 4 | 0.0006 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 12 | 0.0005 |
| 9 | Tetracycline-class Antibacterial [EPC] | 4 | 0.0005 |